Article

Rheumatoid Arthritis Quiz: Adverse Effects of Methotrexate

Author(s):

Ingrid Torjesen

Methotrexate is the first-line treatment for rheumatoid arthritis. As with all drugs, there is a risk of experiencing adverse effects. Do you know what type of adverse effects are most likely with methotrexate and who is likely to experience them? Take this quiz to find out.

Approximately what proportion of patients with rheumatoid arthritis treated with methotrexate report adverse effects during the first year of treatment?


Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Related Content
Digital Cognitive Behavioral Therapy Stanza to be Covered by Highmark Health
February 7th 2025

Digital Cognitive Behavioral Therapy for Fibromyalgia to be Covered by Highmark Health

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
Black and white FDA logo | Credit: US Food and Drug Administration
February 5th 2025

FDA Fast Tracks CAR-T Therapy for Lupus

Abigail Brooks, MA
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Gerd R. Burmester, MD, Professor of Medicine, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, and Humboldt University and Free University
February 4th 2025

Tocilizumab Biosimilar Approved for Rheumatological Diseases, COVID-19

Victoria Johnson
HCPLive Rheumatology Month in Review
February 3rd 2025

Rheumatology Month in Review: January 2025

Victoria Johnson
© 2025 MJH Life Sciences

All rights reserved.